Symbol
| FHL1
| contributors: mct/npt/pgu - updated : 04-03-2015
|
HGNC name
| four and a half LIM domains 1
|
HGNC id
| 3702
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
particularly in the pulmonary vasculature, in lungs from patients with idiopathic pulmonary arterial hypertension | constitutional
|  
|  
| --low
|  
|
in hypertrophic cardiomyopathy and failing hearts | constitutional
|  
|  
| --over
|  
|
in hypertrophic cardiomyopathy (HCM) | constitutional
|  
|  
| --over
|  
|
in smooth muscle in Hirschsprung disease (HSCR) might be associated with intestinal wall remodeling in HSCR and might be one of the risk factors for gastrointestinal motor dysfunction | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neuromuscular | myopathy | | |
FHL1-NFATC1-UTRN signaling axis that can functionally compensate for dystrophin and treat DMD |
| | | |
| W122S mutant mice did not manifest cytoplasmic inclusions (reducing bodies) in muscle, and loss of function is responsible for the late-onset mild myopathy in the Fhl1 W122S knock-in mice |